Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 3/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | CDC25B | P30305 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4089780 | 0.87 | TP53 (0.67) | TP53MAPTALDH1A1TSHRTRPV1 | |
| SCHEMBL21561693 | 0.84 | TP53 (0.58) | AKR1C3TP53MAPTALDH1A1HPGD | |
| SCHEMBL11208187 | 0.83 | AKR1C3 (0.50) | AKR1C3TP53GAAMAPTALDH1A1 | |
| SCHEMBL13159354 | 0.83 | TDP1 (0.42) | AKR1C3TP53GAAALDH1A1CDC25B | |
| SCHEMBL154607 | 0.81 | HPGD (0.53) | TP53GAAMAPTALDH1A1HPGD | |
| SCHEMBL13159486 | 0.81 | TP53 (0.51) | AKR1C3TP53GAAMAPTALDH1A1 | |
| SCHEMBL13159280 | 0.81 | HPGD (0.69) | AKR1C3TP53GAAMAPTALDH1A1 | |
| SCHEMBL25828187 | 0.80 | POLB (0.57) | TP53GAAMAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL27871652 | 0.80 | HPGD (0.52) | TP53GAAMAPTALDH1A1HPGD | |
| SCHEMBL12643814 | 0.79 | ELANE (0.39) | AKR1C3TP53GAAALDH1A1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9708425-B2 | Routes to polyacrylates | COLOPLAST A/S (DK) | 2017-07-18 | — | — | US | claimed |
| US-9371308-B2 | Polymeric photoinitiators | COLOPLAST A/S (DK) | 2016-06-21 | — | — | US | claimed |
| EP-2638078-B1 | NEW ROUTES TO POLYACRYLATES | COLOPLAST AS (DK) | 2015-01-07 | — | — | EP | claimed |
| EP-2638077-B1 | NOVEL POLYMERIC PHOTOINITIATORS | COLOPLAST AS (DK) | 2015-01-07 | — | — | EP | claimed |
| US-20130296454-A1 | ROUTES TO POLYACRYLATES | COLOPLAST A/S (DK) | 2013-11-07 | — | — | US | claimed |
| US-20130289155-A1 | NOVEL POLYMERIC PHOTOINITIATORS | COLOPLAST A/S (DK) | 2013-10-31 | — | — | US | claimed |
| EP-4249518-A1 | POLYMERIZABLE PHOTOINITIATORS | ARKEMA FRANCE (FR) | 2023-09-27 | — | — | EP | disclosed |
| EP-2850111-B1 | NOVEL POLYMERIC PHOTOINITIATORS AND PHOTOINITIATOR MONOMERS | COLOPLAST AS (DK) | 2018-11-21 | — | — | EP | disclosed |
| US-9708425-B2 | Routes to polyacrylates | COLOPLAST A/S (DK) | 2017-07-18 | — | — | US | disclosed |
| US-9670373-B2 | Polymers comprising photoinitiator moieties and dye moieties | LAMBSON LIMITED (GB) | 2017-06-06 | — | — | US | disclosed |
| US-9371308-B2 | Polymeric photoinitiators | COLOPLAST A/S (DK) | 2016-06-21 | — | — | US | disclosed |
| US-9296835-B2 | Polymeric photoinitiators and photoinitiator monomers | COLOPLAST A/S (DK) | 2016-03-29 | — | — | US | disclosed |
| US-20150148441-A1 | NOVEL POLYMERIC PHOTOINITIATORS AND PHOTOINITIATOR MONOMERS | COLOPLAST A/S (DK) | 2015-05-28 | — | — | US | disclosed |
| US-20130296454-A1 | ROUTES TO POLYACRYLATES | COLOPLAST A/S (DK) | 2013-11-07 | — | — | US | disclosed |
| US-20130289155-A1 | NOVEL POLYMERIC PHOTOINITIATORS | COLOPLAST A/S (DK) | 2013-10-31 | — | — | US | disclosed |
| US-20100222454-A1 | DEGRADATION ACCELERATOR FOR POLYMERS AND POLYMER ARTICLE COMPRISING IT | CIBA CORPORATION (US) | 2010-09-02 | — | — | US | disclosed |
| US-20100222454-A1 | DEGRADATION ACCELERATOR FOR POLYMERS AND POLYMER ARTICLE COMPRISING IT | CIBA CORPORATION (US) | 2010-09-02 | — | — | US | disclosed |
| US-20100222454-A1 | DEGRADATION ACCELERATOR FOR POLYMERS AND POLYMER ARTICLE COMPRISING IT | CIBA CORPORATION (US) | 2010-09-02 | — | — | US | disclosed |
| EP-2176210-A1 | DEGRADATION ACCELERATOR FOR POLYMERS AND POLYMER ARTICLE COMPRISING IT | BASF SE (DE) | 2010-04-21 | — | — | EP | disclosed |
| WO-2009016083-A1 | DEGRADATION ACCELERATOR FOR POLYMERS AND POLYMER ARTICLE COMPRISING IT | BASF SE (CH) | 2009-02-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150148441-A1 | NOVEL POLYMERIC PHOTOINITIATORS AND PHOTOINITIATOR MONOMERS | PPOX, ALAD, AAAS | AKR1C3 973/4885TP53 1958/4885GAA 790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.